JP2005526511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526511A5 JP2005526511A5 JP2004506720A JP2004506720A JP2005526511A5 JP 2005526511 A5 JP2005526511 A5 JP 2005526511A5 JP 2004506720 A JP2004506720 A JP 2004506720A JP 2004506720 A JP2004506720 A JP 2004506720A JP 2005526511 A5 JP2005526511 A5 JP 2005526511A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- pharmaceutical composition
- muc
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 102100034256 Mucin-1 Human genes 0.000 claims 4
- 108010008707 Mucin-1 Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 239000013612 plasmid Substances 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 102000053602 DNA Human genes 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000001086 cytosolic effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0212036.8A GB0212036D0 (en) | 2002-05-24 | 2002-05-24 | Vaccines |
| PCT/EP2003/005595 WO2003099193A2 (en) | 2002-05-24 | 2003-05-23 | Vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526511A JP2005526511A (ja) | 2005-09-08 |
| JP2005526511A5 true JP2005526511A5 (https=) | 2006-06-08 |
Family
ID=9937387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004506720A Pending JP2005526511A (ja) | 2002-05-24 | 2003-05-23 | ワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060062798A1 (https=) |
| EP (1) | EP1507861A2 (https=) |
| JP (1) | JP2005526511A (https=) |
| AU (1) | AU2003237701A1 (https=) |
| CA (1) | CA2485733A1 (https=) |
| GB (1) | GB0212036D0 (https=) |
| WO (1) | WO2003099193A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212046D0 (en) * | 2002-05-24 | 2002-07-03 | Glaxo Group Ltd | Vaccines |
| GB0304634D0 (en) * | 2003-02-28 | 2003-04-02 | Glaxo Group Ltd | Vaccines |
| JP5060134B2 (ja) * | 2003-12-12 | 2012-10-31 | ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ | ヒト細胞傷害性Ｔリンパ球のエピトープ及びそのＭＵＣ−１の非ＶＮＴＲ（ｎｏｎ−ｖａｒｉａｂｌｅｎｕｍｂｅｒｏｆｔａｎｄｅｍｒｅｐｅａｔｓｅｑｕｅｎｃｅ）由来のアゴニストエピトープ |
| CA2595778A1 (en) * | 2005-01-28 | 2006-08-03 | Ramot At Tel Aviv University, Ltd. | Anti-muc1 .alpha..beta. antibodies |
| US9140692B1 (en) * | 2010-01-08 | 2015-09-22 | Glycozym, Inc. | Methods of identifying glycopeptides recognized by disease-associated auto-antibodies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744144A (en) * | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| AUPM322393A0 (en) * | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US6548643B1 (en) * | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
| EP1012276A2 (en) * | 1997-02-24 | 2000-06-28 | Therion Biologics Corporation | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| US6228843B1 (en) * | 1999-04-23 | 2001-05-08 | University Technology Corporation | Method of using PKC inhibiting compounds to treat vascular disease |
| JP2003510094A (ja) * | 1999-09-08 | 2003-03-18 | トランジェーヌ、ソシエテ、アノニム | Ｍｕｃ−１由来のペプチド |
| GB9930359D0 (en) * | 1999-12-22 | 2000-02-09 | Glaxo Group Ltd | Novel polypeptides |
| EP1257565A4 (en) * | 2000-02-01 | 2005-04-06 | Austin Research Inst | DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY |
| US7125663B2 (en) * | 2001-06-13 | 2006-10-24 | Millenium Pharmaceuticals, Inc. | Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
| GB0212046D0 (en) * | 2002-05-24 | 2002-07-03 | Glaxo Group Ltd | Vaccines |
-
2002
- 2002-05-24 GB GBGB0212036.8A patent/GB0212036D0/en not_active Ceased
-
2003
- 2003-05-23 CA CA002485733A patent/CA2485733A1/en not_active Abandoned
- 2003-05-23 JP JP2004506720A patent/JP2005526511A/ja active Pending
- 2003-05-23 WO PCT/EP2003/005595 patent/WO2003099193A2/en not_active Ceased
- 2003-05-23 EP EP03735479A patent/EP1507861A2/en not_active Withdrawn
- 2003-05-23 US US10/515,872 patent/US20060062798A1/en not_active Abandoned
- 2003-05-23 AU AU2003237701A patent/AU2003237701A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7121443B2 (ja) | 多用途性且つ効率的な遺伝子発現のためのｒｎａレプリコン | |
| JP2006512300A5 (https=) | ||
| JP2008508859A5 (https=) | ||
| JP7389741B2 (ja) | Ｔ細胞受容体または人工ｔ細胞受容体を発現するためのｒｎａレプリコン | |
| JP2006504654A5 (https=) | ||
| JP2008535800A5 (https=) | ||
| JP2010500399A5 (https=) | ||
| UA96922C2 (en) | Il-12/p40 binding protein | |
| WO2008052770A3 (en) | (base-)modified rna for increasing the expression of a protein | |
| JP2009515831A5 (https=) | ||
| JP2006525796A5 (https=) | ||
| JP2011521654A5 (https=) | ||
| CN102307896A (zh) | 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途 | |
| JP2010017185A5 (https=) | ||
| CN109843323A (zh) | 用于黄病毒疫苗接种的组合物和方法 | |
| WO2006045796A3 (en) | Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof | |
| LU102016B1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| JP2016513115A5 (https=) | ||
| JP2020510426A5 (https=) | ||
| JP2005526520A5 (https=) | ||
| WO2003039225A3 (en) | Antigen arrays comprising rankl for treatment of bone disease | |
| WO2021205079A1 (en) | Novel vaccine compositions | |
| JP2005526511A5 (https=) | ||
| US20070164250A1 (en) | Nanoparticle heating and applications thereof | |
| RU2004134331A (ru) | Антиген muc1 со сниженным числом повторяющихся vntr-блоков |